OPK delivered a loss per share of 4 cents in the fourth quarter of 2025, against an earnings per share of a cent in the prior ...

OPKO Health (OPK) delivered earnings and revenue surprises of +39.39% and +7.56%, respectively, for the quarter ended ...

For the quarter ended December 2025, OPKO Health (OPK) reported revenue of $148.5 million, down 19.1% over the same period last year. EPS came in at -$0.04, compared to $0.01 in the year-ago quarter.

OPKO Health, Inc. (Nasdaq: OPK) announced today that management will be participating in the Jefferies Biotech on the Beach Summit, being held March 10-11, 2026, at 1 Hotel South Beach in Miami.

Opko Health Inc. (NASDAQ:OPK) is one of the best high-return penny stocks to buy right now. On February 10, analysts at H.C.

Opko enters into a $250 million non-dilutive note purchase agreement with HealthCare Royalty (HCRx). Opko says the purchase agreement is secured by its profit share payments from Pfizer received ...

Investors in OPKO Health Inc (Symbol: OPK) saw new options begin trading this week, for the December 17th expiration. One of the key data points that goes into the price an option buyer is willing to ...

Investors in OPKO Health Inc (Symbol: OPK) saw new options become available today, for the December 2022 expiration. One of the key data points that goes into the price an option buyer is willing to ...

Opko Health, Inc. (NASDAQ:OPK) shares are trading higher Thursday after the company announced a $100 million share repurchase program. Opko said it expects to fund the repurchase program from existing ...

The most recent short interest data was recently released by the NASDAQ for the 08/30/2013 settlement date, and Opko Health Inc (NYSE: OPK) is one of the most shorted stocks of the Russell 3000, based ...